Natural and synthetic cannabinoids are widely implicated in the scientific literature as potentially useful drugs for cancer patients to help control nausea, pain and weight loss. Recently and of great interest there is a growing body of strong pre-clinical and limited clinical evidence that cannabinoids may have a direct anti-cancer effect against a number of different cancer types (i.e. NSCLC, Breast, Prostate, Glioma and leukemic cell lines). Well-controlled randomised clinical studies assessing the anti-cancer effects of cannabinoids are lacking, which will be required before cannabinoids could ever be used in the mainstream medical setting providing benefit to cancer patients. Kancerbis Ltd aims to remove the stigma from cannabinoid medicine, conduct robust research to understand the role cannabinoids play in cancer treatment and let the science do the talking.
Kancerbis Ltd is actively wishing to discuss with interested parties: